Patent ID: 7482026

Claim:
A chemical formulation comprising a pharmaceutical carrier, a selenium-compound, and two compounds selected from the group consisting of chondroitin sulfate, glucosamine, and methylsulfonylmethane, wherein the chemical formulation includes about 1 to about 6 milligrams of the selenium-compound, wherein (i) if chondroitin sulfate is present in the chemical formulation, then the chemical formulation includes about 500 to about 5000 milligrams of chondroitin sulfate, (ii) if glucosamine is present in the chemical formulation, then the chemical formulation includes about 1500 to about 5200 milligrams of glucosamine, (iii) if methylsulfonylmethane is present in the chemical formulation, then the chemical formulation includes about 800 to about 3500 milligrams of methylsulfonylmethane, and (iv) the chemical formulation does not include all three compounds, chondroitin sulfate, glucosamine and methylsulfonylmethane.